|[December 02, 2013]
Research and Markets: Biosimilars Market by Product & Application - Global Forecast to 2018
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/73bwmf/biosimilars)
has announced the addition of the "Biosimilars
Market by Product & Application - Global Forecast to 2018"
report to their offering.
The biosimilar product market is segmented into recombinant
non-glycosylated proteins, recombinant glycosylated proteins, and
recombinant peptides. The recombinant non-glycosylated proteins market
is further segmented as insulin, granulocyte colony-stimulating factor
(G-CSF), interferons, and human growth hormone; while the recombinant
glycosylated proteins market is further broken down into erythropoietin,
monoclonal antibodies, and follitropin. Calcitonin and glucagon are
considered in the recombinant peptides market.
The recombinant glycosylated proteins segment is expected to witness the
highest growth due to the increased demand for monoclonal antibodies in
the treatment for cancer (oncology), autoimmune disorders, blood
disorders, and infectious diseases. Oncology will be the fastest-growing
segment and currently accounts for a 25% market share in the global
market in 2013. Following monoclonal antibodies, biosimilars of insulin
will be the fastest-growing products and are estimated to grow at a CAGR
of 35.6% from 2013 to 2018. The growth is attributed to the rise in
incidences of diabetes; ongoing patent expirations of biologic drugs
such as Lantus, Humalog, and Novorapid; and the cost effectiveness of
the biosimilars of insulin.
The global market is highly consolidated with the top three players,
naely, Sandoz (Germany), Hospira (U.S.), and Teva (Israel) accounting
for approximately 90% of the market share. Other notable players in the
market include Dr. Reddy's Laboratories (India), Biocon Ltd. (India),
Mylan (U.S.), Biopartners (Switzerland), Amgen (U.S.), and
IntasBiopharmaceutical Ltd. (India).
The competitive landscape covers the growth strategies adopted by the
industry players in the last three years. The company profiles comprise
of the basic views on the key players in the biosimilars market and the
product portfolios, developments, and strategies adopted to maintain and
increase their market shares in the near future. The above-mentioned
market research data, current market size, and forecast of future trends
will help the key players and new entrants to make the necessary
decisions regarding product offerings, geographic focus, change in
strategic approach, R&D investments for innovations in products and
technologies, and levels of output in order to remain successful.
This study covers the revenue market of recombinant glycosylated
proteins, recombinant non-glycosylated proteins, and recombinant
peptides, the three major drug classes of the market. The sales revenue
of each biosimilar drug was considered to estimate the global market.
The market revenue for each therapeutic area was calculated based on the
type of drugs used to treat a particular disease. The market share of
the key players involved in manufacturing and commercializing biosimilar
products was considered to estimate the market.
Key Topics Covered:
Global Biosimilars Market, By Product
Global Biosimilars Market, By Application
Global Biosimilars Service Market
Company Profiles (Overview, Financials, Products & Services, Strategy, &
*Details On Financials, Product & Services, Strategy, & Developments
Might Not Be Captured In Case Of Unlisted Companies.
List of Tables (80 Tables)
List of Figures (80 Figures)
- Actavis, Inc
- Amgen, Inc
- Biocon Ltd
- Celltrion, Inc
- Cipla Ltd
- Dr Reddy's Laboratories Ltd
- Emcure Pharmaceuticals Ltd
- Hospira, Inc
- Lg Life Sciences Ltd
- Merck Kgaa
- Mylan, Inc
- Ranbaxy Laboratories Ltd
- Roche Holding Ltd
- Sandoz International GMBH (Division Of Novartis International Ag)
- Stada Arzneimittel Ag
- Teva Pharmaceutical Industries Ltd
- Wockhardt Ltd
For more information visit http://www.researchandmarkets.com/research/73bwmf/biosimilars
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]